SUBQ-HF is a multicenter clinical trial of selected AHF patients with persistent congestion after initial stabilization. This study will evaluate a strategy of early discharge with daily SQ furosemide compared to usual care in a population who have been initially stabilized but have objective evidence of persistent congestion requiring ongoing parenteral diuretics. This will be an unblinded, randomized, controlled study of approximately 300 evaluable patients. Eligible patients will be randomized (1:1) to either: